Medical Cannabis Research

Medical Marijuana Laws and Suicide

Marijuana and Suicide Rates | Medical Marijuana Laws & Suicide

Mental health and suicide rates – this discussion paper published in 2012, states, “Our results suggest that the passage of a medical marijuana law is associated with an almost 5 percent reduction in the total suicide rate, an 11 percent reduction in the suicide rate of 20- through 29-year-old males, and a 9 percent reduction in the suicide rate of 30- through 39-year-old males.” read more…

Human Cannabinoid Receptor Gene Associated With Happiness

Human Cannabinoid Receptor Gene Associated With Happiness | Cannabis and Mood

This 2014 study out of Japan indicated that genetic traits, specifically the CB1 receptor gene genotypes, are closely related to happiness. C allele carriers of the SNP of CNR1 who are sensitive to positive emotional stimuli may experience a higher magnitude pleasure response when they experience positive events and may have a higher subjective happiness level. read more…

The Effect Of Medical Marijuana Laws On Crime

The Effect Of Medical Marijuana Laws On Crime | Medical Marijuana and Crime

Relying on U.S. state panel data, researchers in Texas analyzed the association between state medical marijuana legalization (MML) and state crime rates for all Part I offenses collected by the FBI. The results did not indicate a crime exacerbating effect of MML on any of the Part I offenses. Alternatively, state medical marijuana legalization may be correlated with a reduction in homicide and assault rates, net of other covariates. read more…

Alzheimer’s Disease & Cannabinoids

Medical Cannabis for Alzheimer Disease | Marijuana Alzheimer's

Results from a 2005 study out of Spain, published in the Journal of Neuroscience, indicate that cannabinoid receptors are important in the pathology of Alzheimer’s Disease and that cannabinoids succeed in preventing the neurodegenerative process occurring in the disease. read more…

Schizophrenia & Cannabis

Schizophrenia and Cannabis Use | Schizophrenia Cannabis

The results of this 2013 study out of Harvard suggest that having an increased familial morbid risk for schizophrenia may be the underlying basis for schizophrenia in cannabis users and not cannabis use by itself. read more…

Crohn’s Disease & THC

Crohn's Disease & THC | Cannabis Research | THC Research

A 2013 study Published in the journal Pharmacology involved 21 patients with Crohn’s disease unresponsive to standard IBD treatment. The study was able to demonstrate that an 8-week treatment with tetrahydrocannabinol (THC)-rich cannabis caused a decrease in the Crohn’s disease activity index in 90% of patients without producing significant side effects. read more…

THC & Exercise Performance

THC And Exercise Performance | THC Research

In a 2013 issue of the journal Nutrition & Metabolism, four drugs (ethanol, caffeine, nicotine & THC) were evaluated for their effect on exercise metabolism. Overall, it appears that cannabis does not have ergogenic potential in sports activities and thus, its inclusion on the banned list is likely a function of its illicitness. read more…

Cannabinoid Receptor Pharmacology

Cannabinoid Receptor Pharmacology | Cannabinoid Receptor Agonists

Cannabis sativa is the source of a unique set of compounds known collectively as plant cannabinoids or phytocannabinoids. This review published in 2008 in the Journal of British Pharmacology focuses on the manner with which three of these compounds, (_)-trans-D9-tetrahydrocannabinol (D9-THC), (_)-cannabidiol (CBD) and (_)-trans-D9-tetrahydrocannabivarin (D9-THCV), interact with cannabinoid receptors CB1 and CB2. read more…

Inhibition Of Human Tumour Prostate PC-3 Cell Growth

Cannabis and Prostate Cancer | Prostate Cancer Treatments

Cannabis and Prostate cancer: There is considerable interest in the application of selective CB2 receptor agonists, which are devoid of typical marijuana-like psychoactive properties of CB1 agonists, for future cannabinoid-based anticancer therapies. This study, done in Spain and published in the British Journal of Cancer in 2009, has findings that point to the potential application of cannabinoid receptor type 2 ligands as anti-tumour agents in prostate cancer. read more…

MS Spasticity, THC:CBD Cannabis Spray, And Driving

MS Spasticity, THC:CBD Cannabis Spray, And Driving | Cannabis and Multiple Sclerosis

Cannabis and Multiple Sclerosis: Is driving safe for MS patients who use cannabis for resistant spasticity? In this poster presentation by German neurologists they show that THC:CBD oromucosal spray (Sativex), when used for 4-6 weeks by patients with multiple sclerosis, did not harm driving skills. As a matter of fact, there was significant improvement in a motor reaction task test. read more…

Page 6 of 12« First...234567891011...Last »